 |
|
Europe mobilises full research potential to combat poverty-related diseases EDCTP launch conference, Barcelona, 19-20 April 2002
April 16, 2002On 19-20 April, 2002, a conference, co-organised by the European Commission (DG Research) and the Spanish Presidency, will launch the first phase of the European-Developing Countries Clinical Trials Programme (EDCTP) - a new programme to accelerate the clinical development of drugs and vaccines against poverty-related diseases: AIDS, malaria and tuberculosis. The EDCTP initiative is intended to bridge the gap between dispersed research efforts in Europe and the production of drugs and vaccines for Developing Countries.
The establishment of a clinical trials programme tailored to the needs of developing countries addresses the major global priority to combat the major poverty-related diseases - AIDS, malaria and tuberculosis. These diseases kill over 5 million people each year and cause massive disruption to the economies of developing countries. This vicious circle of poverty and disease makes it increasingly difficult to combat these diseases. The situation is particularly critical in sub-Saharan Africa, where the European-Developing Countries Clinical Trials Programme (EDCTP) has decided to focus its attention initially. Of even greater concern is the fact that today there is no suitable effective way to prevent AIDS, malaria or TB. This is partly due to the economic situation in Developing Countries which makes significant industrial investment in those diseases commercially unviable for the private sector. Thus it is the responsibility of the public sector to bridge this gap.
"Europe can contribute significantly to the response to the global problem of poverty-related diseases if it brings together its dispersed forces [in research and development] in a coherent manner. It is important for public authorities to initiate the process because clearly there will not necessarily be an economic return for industry," said European Commissioner for Research Philippe Busquin. However, industry may join and may wish to create a public-private partnership if they see that the public sector is ready to share part of the risk.
The European Commission is strongly committed to the EDCTP initiative and proposes to contribute EUR200 million in the next European research Framework programme (2002-2006). To "Stress the health and education focus of the EU's development co-operation policies as part of its over-arching objective to combating poverty" is one of the Commission's seven core priorities for 2002 . In this global political framework, the Programme "Accelerated action against HIV/AIDS, malaria and tuberculosis" in the context of poverty reduction adopted by the European Council on 15 May 2001 is based on three pillars: trade, development and research. For the latter, it will be the first attempt of a joint research programme between the European Community and the Member or Associated States in line with idea of a European Research Area. "The idea is that Europe, through a series of joint programmes directed at basic research and development and through clinical trials of new drugs and vaccines or other therapies, can contribute to better prevention, better control and better treatment of these diseases in Developing Countries," said EDCTP member Dr. Antoni Trilla from the Hospital Clinic Barcelona.
The European Commission, together with 15 European countries has recognised this emergency and the urgent need to pool all forces. In the joint programme of the EDCTP European research efforts will be mobilised in a coherent fashion. The EDCTP will exploit the vast amounts of relevant research results already generated within the respective national research programmes by enabling the clinical testing of promising vaccines and drugs and their rapid transfer to clinical application. The integration of Community and national programmes will be achieved by co-ordinating, networking and pooling of research activities. The EDCTP should provide incentives for industry to join. Therefore, the major goal of the EDCTP is to move new vaccines and drugs from basic research into clinical trials, conducted under the highest quality and ethical standards.
The purpose of this conference will be to launch the first phase of the EDCTP and to gather strong political support for this initiative. This first phase, which is expected to last 12 months and is funded by a EUR1.2 million grant from the European Commission, is led by the Hospital Clinic of Barcelona.
The conference
Representatives of European countries and African delegates have been meeting over the past few months and have worked closely together to define the EDCTP's strategy, priorities and modus operandi. This EDCTP launch conference brings together the main actors from European and African governments, the scientific community, international organisations, foundations and pharmaceutical companies. It is intended to formerly introduce and explain the EDCTP initiative to all stakeholders.
Political figures participating in the event include Mr Pascal Mucumbi, Prime Minister of Mozambique; Mrs Awa Coll-Seck, Minister for Health of Senegal; Mrs Celia Villalobos, Spanish Minister for Health; Mr Ramon Marimon, Secretary of State for Science and Technology; and Mr Philippe Busquin, European Commissioner for Research.
The conference will begin at 10:00 with the presentation of the EDCTP. The first day of the conference will concentrate on health policy and funding issues. The second day will focus on health research for development with leading researchers and healthcare experts on the prevention and treatment of these diseases, with specific sessions for each of the three diseases. The conference programme is available on-line: http://europa.eu.int/comm/research/edctp.html.
A press conference will be held on the first day from 11:00-11:45, followed by a lunch with all the speakers. There will also be opportunities to interview high level scientists and political figures from Europe and Africa.
European Commission, Research Directorate
Malaria Current Events and Malaria News RSSStopping germs from ganging up on humans
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
Applying 'supply and demand' business principles to treat infectious diseases worldwide
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases.
'Airport malaria' -- cause for concern in the US
In a global world, significant factors affect the spread of infectious diseases, including international trade, air travel and globalized food production. "Airport malaria" is a term coined by researchers to explain the more recent spread of malaria to areas such as the United States and Europe, which some scientists credit to warmer climate changes.
Dramatic fall in malaria in the Gambia raises possibility of elimination in parts of Africa
The incidence of malaria has fallen significantly in The Gambia in the last 5 years, according to a study carried out by experts there with support from scientists based in London.
Researchers characterize potential protein targets for malaria vaccine
Researchers from Nijmegen and Leiden have now characterized a large number of parasite proteins that may prove useful in the development of a human malaria vaccine.
Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows.
Neighborhood greenness has long term positive impact on kids' health
In the first study to look at the effect of neighborhood greenness on inner city children's weight over time, researchers from the Indiana University School of Medicine, Indiana University-Purdue University Indianapolis and the University of Washington report that higher neighborhood greenness is associated with slower increases in children's body mass over a two year period, regardless of residential density.
Childhood environmental health
Children are exposed to a wide range of environmental threats that can affect their health and development early in life, throughout their youth and into adulthood.
Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/).
Governments urged to fight global child killer
Pneumococcal disease, one of the world's leading causes of death and serious illness, must be recognised as an urgent global health issue together with HIV, malaria and TB, say the UK All-Party Parliamentary Group (APPG) on Pneumococcal Disease Prevention in the Developing World in a report launching at the House of Lords today.
More Malaria Current Events and Malaria News Articles
 | The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard Malaria sickens hundreds of millions of people -- and kills one to three million -- each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe?From Russia to... |
 | Malaria Dreams: An African Adventure by Stuart Stevens Malaria Dreams is a tale of high adventure across Africa, recounted with the wit and humor that delighted readers of Night Train to Turkistan, Stuart Stevens' highly praised first book. "A rollicking, off-beat African odyssey".--Publishers... |
 | Molecular Approaches to Malaria "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. An important resource for molecular biologists, biochemists, cell biologists, chemists, pathologists, parasitologists, entomologists, and immunologists,... |
 | The Conquest of Malaria: Italy, 1900-1962 by Frank Snowden At the outset of the twentieth century, malaria was Italy’s major public health problem. It was the cause of low productivity, poverty, and economic backwardness, while it also stunted literacy, limited political participation, and undermined the army. In this book Frank Snowden recounts how Italy became the world center for the development of malariology as a medical discipline and launched... |
 | The Miraculous Fever-Tree: Malaria and the Quest for a Cure That Changed the World by Fiammetta Rocco "Cinchona revolutionized the art of medicine as profoundly as gunpowder had the art of war." -- Bernardino Ramazzini, Physician to the Duke of Modena, Opera omnia, medica, et physica, 1716 In the summer of 1623, ten cardinals and hundreds of their attendants died in Rome while electing a new pope. The Roman marsh fever that felled them was the scourge of the Mediterranean, northern Europe... |
| War and Disease: Biomedical Research on Malaria in the Twentieth Century (Critical Issues in Health and Medicine) (Critical Issues in Health and Medicine) by Leo B. Slater Malaria is one of the leading killers in the world today. Though drugs against malaria have a long history, attempts to develop novel therapeutics spanned the twentieth century and continue today. In this historical study, Leo B. Slater shows the roots and branches of an enormous drug development project during World War II. Fighting around the globe, American soldiers were at high risk for... | |
 | Malaria Methods and Protocols (Methods in Molecular Medicine) (Methods in Molecular Medicine) Internationally respected scientists and clinicians describe in step-by-step detail their most useful conventional and cutting-edge techniques for the study of malaria. Areas covered include clinical and laboratory diagnosis and typing, animal models, molecular biology, immunology, cell biology, vaccinology, laboratory models, and field applications. Each readily reproducible protocol has been... |
 | Malaria - a Handbook for Health Professionals by Malaria Consortium |
 | Malaria (Diseases and Disorders) by Melissa Abramovitz Malaria is a serious disease which affects millions of people and kills many children each day. This book explores how families cope with frequent bouts of malaria and explains what causes the disease, how it is spread, and what is being done to treat and prevent it.... |
 | First Comes Love, Then Comes Malaria: How a Peace Corps Poster Boy Won My Heart and a Third World Adventure Changed My Life by Eve Brown-Waite Eve Brown, college diploma in hand and notions of saving the world in her head, was unsure about what to do with the rest of her life. Something noble...yet glamorous, she hoped. With some ambivalence she looked into joining the Peace Corps. When she fell for her dashing and altruistic Peace Corps recruiter, John, all the ambivalence disappeared. She absolutely had to join the Peace Corps, if... |
| © 2008 BrightSurf.com |